2018
Chapter 22 Current Status of Medical Therapy of Thoracic Aortic Aneurysm and Dissection
Percy A, Mukherjee S, Ziganshin B, Elefteriades J. Chapter 22 Current Status of Medical Therapy of Thoracic Aortic Aneurysm and Dissection. 2018, 235-249. DOI: 10.1016/b978-0-12-809979-7.00022-5.Peer-Reviewed Original ResearchThoracic aortic aneurysmAortic aneurysmMost thoracic aortic aneurysmsAngiotensin receptor blockersClasses of medicationsAortic aneurysm developmentRelevant clinical endpointsAortic aneurysm expansionAsymptomatic patientsLifestyle modificationReceptor blockersMedical therapySurgical repairAortic catastropheClinical evidencePathophysiologic pathwaysSurgical interventionPathophysiologic basisTreatment modalitiesAneurysm expansionClinical endpointsClinical trialsCurrent guidelinesAneurysm formationClinical studies
2017
Medical management of aortic disease in Marfan syndrome.
Bin Mahmood SU, Velasquez CA, Zafar MA, Saeyeldin AA, Brownstein AJ, Ziganshin BA, Elefteriades JA, Mukherjee SK. Medical management of aortic disease in Marfan syndrome. Annals Of Cardiothoracic Surgery 2017, 6: 654-661. PMID: 29270377, PMCID: PMC5721117, DOI: 10.21037/acs.2017.11.09.Peer-Reviewed Original ResearchAngiotensin receptor blockersMedical managementMarfan syndromeMFS patientsThoracic aortic aneurysm diseaseDifferent medical regimensStandard of careAortic aneurysm diseaseNumerous pathophysiological effectsAortic dilatationReceptor blockersAortic diseaseMedical regimensCurrent guidelinesAneurysm diseaseCardiovascular organsΒ-blockersCurrent evidencePathophysiological effectsHereditary disorderPatientsSyndromeDiseaseRegimensManagement
2015
Atenolol versus Losartan in Marfan's Syndrome
Ziganshin B, Mukherjee S, Elefteriades J. Atenolol versus Losartan in Marfan's Syndrome. New England Journal Of Medicine 2015, 372: 977-981. PMID: 25738681, DOI: 10.1056/nejmc1500128.Peer-Reviewed Original Research
2013
Medical Treatment for Thoracic Aortic Aneurysm – Much More Work To Be Done
Chun AS, Elefteriades JA, Mukherjee SK. Medical Treatment for Thoracic Aortic Aneurysm – Much More Work To Be Done. Progress In Cardiovascular Diseases 2013, 56: 103-108. PMID: 23993243, DOI: 10.1016/j.pcad.2013.05.008.Peer-Reviewed Original ResearchConceptsReceptor blockersAortic diseaseAortic aneurysmMedical treatmentBeta-adrenergic receptor blockersAngiotensin receptor blockersAortic aneurysm repairForms of pharmacotherapyThoracic aortic diseaseThoracic aortic aneurysmMatrix metalloproteinase inhibitorsAortic surgeryAortic expansionAneurysm repairAortic ruptureMedical therapySurgical repairSurgical interventionAortic riskAortic valveGuideline criteriaMaximal diameterMetalloproteinase inhibitorsFuture riskAneurysms